Liu SY - Search Results

1

Reducing false positive rate of docking-based virtual screening by active learning.

Wang L, Shi SH, Li H, Zeng XX, Liu SY, Liu ZQ, Deng YF, Lu AP, Hou TJ, Cao DS. Wang L, et al. Among authors: liu sy, liu zq. Brief Bioinform. 2023 Jan 19;24(1):bbac626. doi: 10.1093/bib/bbac626. Brief Bioinform. 2023. PMID: 36642412

2

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.

Zou Z, Hu X, Luo T, Ming Z, Chen X, Xia L, Luo W, Li J, Xu N, Chen L, Cao D, Wen M, Kong F, Peng K, Xie Y, Li X, Ma D, Yang C, Chen C, Yi W, Liu O, Liu S, Luo J, Luo Z. Zou Z, et al. Nat Commun. 2021 Apr 15;12(1):2263. doi: 10.1038/s41467-021-22235-8. Nat Commun. 2021. PMID: 33859183 Free PMC article.

3

Design, Synthesis, and Biological Activity of Novel Quinone Derivatives as Potent STAT3 Inhibitors for Psoriasis Treatment.

Chen L, Wang L, Gao J, Xie Y, Deng X, Tian G, Li M, Sui Z, Luo C, Liu L, Huang X, Zhu X, Zhu S, Luo Z, Ma D, Liu S. Chen L, et al. J Med Chem. 2024 Sep 12;67(17):15438-15455. doi: 10.1021/acs.jmedchem.4c01055. Epub 2024 Aug 16. J Med Chem. 2024. PMID: 39151117

4

Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway.

Peng K, Zou Z, Li J, Xie Y, Ming Z, Jiang T, Luo W, Hu X, Nie Y, Chen L, Luo T, Peng T, Ma D, Liu S, Luo ZY. Peng K, et al. J Nat Prod. 2023 Sep 22;86(9):2111-2121. doi: 10.1021/acs.jnatprod.3c00276. Epub 2023 Sep 8. J Nat Prod. 2023. PMID: 37682035

5

ZLM-7 Blocks Breast Cancer Progression by Inhibiting MDM2 via Upregulation of 14-3-3 Sigma.

Wen M, Zou ZZ, Luo T, Li X, Liu SY, Li JJ, Luo ZY. Wen M, et al. Among authors: liu sy. Pharmaceuticals (Basel). 2022 Jul 15;15(7):874. doi: 10.3390/ph15070874. Pharmaceuticals (Basel). 2022. PMID: 35890172 Free PMC article.

6

An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation.

Xie Y, Zhu S, Chen L, Liu H, Peng T, Ming Z, Zou Z, Hu X, Luo W, Peng K, Nie Y, Luo T, Ma D, Liu S, Luo Z. Xie Y, et al. Cancers (Basel). 2023 Apr 23;15(9):2424. doi: 10.3390/cancers15092424. Cancers (Basel). 2023. PMID: 37173892 Free PMC article.

7

Synthesis and biological evaluation of novel isoxazoloquinone derivatives as potent STAT3-targeting antipsoriasis agents.

Chen L, Zhu S, Xie Y, Wang L, Gao J, Luo T, Li J, Deng X, Ma D, Liu S, Luo Z. Chen L, et al. Bioorg Chem. 2024 Oct;151:107617. doi: 10.1016/j.bioorg.2024.107617. Epub 2024 Jul 8. Bioorg Chem. 2024. PMID: 39053100

8

ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.

Li X, Zou ZZ, Wen M, Xie YZ, Peng KJ, Luo T, Liu SY, Gu Q, Li JJ, Luo ZY. Li X, et al. Among authors: liu sy. Mol Med. 2020 Nov 13;26(1):109. doi: 10.1186/s10020-020-00239-2. Mol Med. 2020. PMID: 33187481 Free PMC article.

9

Exploration of inhibitors targeting KIF18A with ploidy-specific lethality.

Chen Q, Le X, Li Q, Liu S, Chen Z. Chen Q, et al. Drug Discov Today. 2024 Oct;29(10):104142. doi: 10.1016/j.drudis.2024.104142. Epub 2024 Aug 19. Drug Discov Today. 2024. PMID: 39168405 Review.

10

The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4.

Su M, Huang J, Liu S, Xiao Y, Qin X, Liu J, Pi C, Luo T, Li J, Chen X, Luo Z. Su M, et al. Sci Rep. 2016 Jun 24;6:28139. doi: 10.1038/srep28139. Sci Rep. 2016. PMID: 27338725 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,529 results

Search Page

Filters